A 17β-Estradiol–Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women

A 17β-Estradiol–Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women

Obstetrics and Gynecology ◽

10.1097/aog.0000000000002645 ◽

2018 ◽

Vol 132 (1) ◽

pp. 161-170 ◽

Cited By ~ 27

Author(s):

Rogerio A. Lobo ◽

David F. Archer ◽

Risa Kagan ◽

Andrew M. Kaunitz ◽

Ginger D. Constantine ◽

...

Keyword(s):

Postmenopausal Women ◽

Vasomotor Symptoms ◽

17Β Estradiol ◽

A 17β-Estradiol–Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women

Obstetrical & Gynecological Survey ◽

10.1097/01.ogx.0000549834.30469.f2 ◽

2018 ◽

Vol 73 (11) ◽

pp. 630-632

Author(s):

Rogerio A. Lobo ◽

David F. Archer ◽

Risa Kagan ◽

Andrew M. Kaunitz ◽

Ginger D. Constantine ◽

...

Keyword(s):

Postmenopausal Women ◽

Vasomotor Symptoms ◽

17Β Estradiol ◽

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms

Menopause The Journal of The North American Menopause Society ◽

10.1097/gme.0000000000001271 ◽

2019 ◽

Vol 26 (5) ◽

pp. 506-512 ◽

Cited By ~ 10

Author(s):

James A. Simon ◽

Andrew M. Kaunitz ◽

Robin Kroll ◽

Shelli Graham ◽

Brian Bernick ◽

...

Keyword(s):

Quality Of Life ◽

Postmenopausal Women ◽

Vasomotor Symptoms ◽

Percutaneous 17β-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women

Menopause The Journal of The North American Menopause Society ◽

10.1097/01.gme.0000070526.74726.8a ◽

2003 ◽

Vol 10 (6) ◽

pp. 516-521 ◽

Cited By ~ 19

Author(s):

David F. Archer

Keyword(s):

Postmenopausal Women ◽

Vasomotor Symptoms ◽

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women

Menopause The Journal of The North American Menopause Society ◽

10.1097/gme.0b013e31829c1431 ◽

2014 ◽

Vol 21 (3) ◽

pp. 227-235 ◽

Cited By ~ 18

Author(s):

David F. Archer ◽

Thomas Schmelter ◽

Matthias Schaefers ◽

Christoph Gerlinger ◽

Kerstin Gude

Keyword(s):

Effective Dose ◽

Postmenopausal Women ◽

Controlled Study ◽

Vasomotor Symptoms ◽

Double Blind ◽

Double Blind Placebo ◽

Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women

Menopause The Journal of The North American Menopause Society ◽

10.1097/gme.0000000000001278 ◽

2018 ◽

Vol 26 (6) ◽

pp. 622-628 ◽

Cited By ~ 7

Author(s):

Risa Kagan ◽

Ginger Constantine ◽

Andrew M. Kaunitz ◽

Brian Bernick ◽

Sebastian Mirkin

Keyword(s):

Postmenopausal Women ◽

17Β Estradiol ◽

Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptoms

Maturitas ◽

10.1016/j.maturitas.2020.05.002 ◽

2020 ◽

Vol 139 ◽

pp. 20-26

Author(s):

Sophia Tsiligiannis ◽

Bettina C. Wick-Urban ◽

Jan van der Stam ◽

John C. Stevenson

Keyword(s):

Hormone Replacement Therapy ◽

Replacement Therapy ◽

Postmenopausal Women ◽

Low Dose ◽

Hormone Replacement ◽

Vasomotor Symptoms ◽

Efficacy And Safety ◽

REPLENISH trial: Endometrial protection with a 17β-estradiol and progesterone combination (TX-001HR) in postmenopausal women with vasomotor symptoms

Maturitas ◽

10.1016/j.maturitas.2017.03.282 ◽

2017 ◽

Vol 100 ◽

pp. 130

Author(s):

Sebastian Mirkin ◽

Shelli Graham ◽

Ginger Constantine ◽

James Pickar ◽

Gina Gasper ◽

...

Keyword(s):

Postmenopausal Women ◽

Vasomotor Symptoms ◽

Novel oral combined 17β-estradiol (E2) and micronized progesterone (P4) therapy improves vasomotor symptoms (VMS) and sleep in postmenopausal women (PW)

Maturitas ◽

10.1016/j.maturitas.2021.08.054 ◽

2021 ◽

Vol 152 ◽

pp. 85

Author(s):

James H. Pickar ◽

Shelli Graham ◽

Renata Zablotna ◽

Mitra Boolell ◽

Sebastian Mirkin

Keyword(s):

Postmenopausal Women ◽

Vasomotor Symptoms ◽

17Β Estradiol ◽

Micronized Progesterone

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms

Menopause The Journal of The North American Menopause Society ◽

10.1097/gme.0b013e31829c12e8 ◽

2014 ◽

Vol 21 (3) ◽

pp. 236-242 ◽

Cited By ~ 3

Author(s):

Gabriele Sutter ◽

Thomas Schmelter ◽

Kerstin Gude ◽

Matthias Schaefers ◽

Christoph Gerlinger ◽

...

Keyword(s):

Postmenopausal Women ◽

Low Dose ◽

Vasomotor Symptoms ◽

Population Pharmacokinetic ◽